These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1505606)

  • 1. The effect of three different oral doses of verapamil on the disposition of theophylline.
    Stringer KA; Mallet J; Clarke M; Lindenfeld JA
    Eur J Clin Pharmacol; 1992; 43(1):35-8. PubMed ID: 1505606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of verapamil on the pharmacokinetic disposition of theophylline in cigarette smokers.
    Gin AS; Stringer KA; Welage LS; Wilton JH; Matthews GE
    J Clin Pharmacol; 1989 Aug; 29(8):728-32. PubMed ID: 2778093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of calcium channel blockers on theophylline disposition.
    Sirmans SM; Pieper JA; Lalonde RL; Smith DG; Self TH
    Clin Pharmacol Ther; 1988 Jul; 44(1):29-34. PubMed ID: 3391002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil-induced inhibition of theophylline elimination in healthy humans.
    Nielsen-Kudsk JE; Buhl JS; Johannessen AC
    Pharmacol Toxicol; 1990 Feb; 66(2):101-3. PubMed ID: 2315261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosing.
    Busse D; Fromm MF; Mörike K; Drescher S; Kühlkamp V; Eichelbaum M
    Clin Pharmacol Ther; 2001 May; 69(5):324-32. PubMed ID: 11372000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of verapamil on theophylline serum concentrations.
    Rindone JP; Zuniga R; Sock JA
    Drug Metabol Drug Interact; 1989; 7(2-3):143-7. PubMed ID: 2698316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR; Egan JM; Dickinson TH; Carrum G
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.
    Murdoch DL; Thomson GD; Thompson GG; Murray GD; Brodie MJ; McInnes GT
    Br J Clin Pharmacol; 1991 Mar; 31(3):323-32. PubMed ID: 2054272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
    Langston VC; Koritz GD; Davis LE; Neff-Davis C
    Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of theophylline elimination in rabbits by verapamil.
    Nielsen-Kudsk JE
    Pharmacol Toxicol; 1989 Apr; 64(4):349-51. PubMed ID: 2748541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of intravenous cimetidine dosage regimens on the disposition of theophylline.
    Gutfeld MB; Welage LS; Walawander CA; Wilton JH; Harrison NJ
    J Clin Pharmacol; 1989 Jul; 29(7):665-9. PubMed ID: 2760260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.
    McAllister RG; Kirsten EB
    Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-linear pharmacokinetics of high-dose intravenous verapamil.
    Toffoli G; Robieux I; Fantin D; Gigante M; Frustaci S; Nicolosi GL; De Cicco M; Boiocchi M
    Br J Clin Pharmacol; 1997 Sep; 44(3):255-60. PubMed ID: 9296319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the pharmacokinetics and electrocardiographic effects of intravenous verapamil with intravenous calcium chloride pretreatment in normal subjects.
    Schoen MD; Parker RB; Hoon TJ; Hariman RJ; Bauman JL; Beckman KJ
    Am J Cardiol; 1991 Feb; 67(4):300-4. PubMed ID: 1990794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of the renal excretion of theophylline on its plasma concentrations and urine flow rate in asthmatic children.
    Agbaba D; Pokrajac M; Varagić VM; Pesić V
    J Pharm Pharmacol; 1990 Dec; 42(12):827-30. PubMed ID: 1983143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fluconazole on theophylline disposition in humans.
    Konishi H; Morita K; Yamaji A
    Eur J Clin Pharmacol; 1994; 46(4):309-12. PubMed ID: 7957514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate.
    Ahmed JH; Godden J; Meredith PA; Elliott HL
    Br J Clin Pharmacol; 1993 Aug; 36(2):93-8. PubMed ID: 8398588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quinolone, flumequine, has no effect on theophylline pharmacokinetics.
    Lacarelle B; Blin O; Audebert C; Auquier P; Karsenty H; Horriere F; Durand A
    Eur J Clin Pharmacol; 1994; 46(5):477-8. PubMed ID: 7957547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tobacco smoking and oral contraceptive use on theophylline disposition.
    Gardner MJ; Tornatore KM; Jusko WJ; Kanarkowski R
    Br J Clin Pharmacol; 1983 Sep; 16(3):271-80. PubMed ID: 6626419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.